Table 1.

Baseline characteristics of patients with WMHs and controls without WMHs

Category	Patients with WMHs		Controls (n=16)	P value
	≤5 WMLs (n=16)	>5 WMLs (n=16)
Age (mean±SD, year)	44.06±6.13	44.00±6.89	42.75±6.26	0.81
Female, n (%)	7 (43.8)	6 (37.5)	6 (37.5)	0.917
Current smoker, n (%)	3 (18.8)	3 (18.8)	2 (12.5)	1
Alcohol user, n (%)	0 (0.0)	1 (6.3)	3 (18.8)	0.304
Hypertension, n (%)	1 (6.3)	3 (18.8)	2 (12.5)	0.859
Diabetes mellitus, n (%)	0 (0.0)	0 (0.0)	1 (6.3)	1
Hyperlipidaemia, n (%)	2 (12.5)	5 (31.3)	3 (18.8)	0.556
Lacunes, n(%)	0 (0.0)	3 (18.6)	0 (0.0)	0.097
CMBs, n(%)	1 (6.3)	1 (6.3)	0 (0.0)	1

CMBs, cerebral microbleeds; WMH, white matter hyperintensity; WML, white matter lesion.